First-line gemcitabine plus nab-paclitaxel for elderly patients with metastatic pancreatic cancer: Crossing the frontier of age?

导出 LinkOut

翻译打印收藏纠错

作者： Caterina,Vivaldi ^[1] ; Francesca,Salani ^[2] ; Giulia,Rovesti ^[3] ; Irene,Pecora ^[2] ; Silvia,Catanese ^[2] ; Andrea,Casadei-Gardini ^[4] ; Valentina,Massa ^[2] ; Laura,Bernardini ^[2] ; Laura,Riggi ^[3] ; Kalliopi,Andrikou ^[3] ; Giovanni I,Rapposelli ^[4] ; Vincenzo,Formica ^[5] ; Monica,Lencioni ^[2] ; Alfredo,Falcone ^[1] ; Enrico,Vasile ^[2] ; Lorenzo,Fornaro ^[6]

作者单位： Unit of Medical Oncology, Azienda Ospedaliero-Universitaria Pisana, Via Roma 67, Pisa, 56126, Italy; Department of Translational Research and New Surgical and Medical Technologies, University of Pisa, Via Savi 6, Pisa, 56126, Italy. ^[1] Unit of Medical Oncology, Azienda Ospedaliero-Universitaria Pisana, Via Roma 67, Pisa, 56126, Italy. ^[2] Department of Oncology and Hematology, Division of Oncology, University of Modena and Reggio Emilia, Via del Pozzo 71, Modena, 41100, Italy. ^[3] Department of Medical Oncology, Istituto Scientifico Romagnolo per Lo Studio e La Cura Dei Tumori (IRST) IRCCS, Via P. Maroncelli N. 40, Meldola, 47014, Italy. ^[4] Medical Oncology Unit, Tor Vergata University, Viale Oxford 81, Rome, 00133, Italy. ^[5] Unit of Medical Oncology, Azienda Ospedaliero-Universitaria Pisana, Via Roma 67, Pisa, 56126, Italy. Electronic address: lorenzo.fornaro@gmail.com. ^[6]

关键词 Elderly First-line chemotherapy Gemcitabine Metastatic pancreatic cancer Nab-paclitaxel